Research to Prevent Blindness and Castle Biosciences are partnering to provide new opportunities for medical students to pursue ocular cancer research.
Research to Prevent Blindness and Aerie Pharmaceuticals are partnering to provide grant opportunities to support novel research in glaucoma.
RPB and the AOCOO-HNS Foundation are launching a multi-year partnership to provide funding to increase research opportunities in vision science for students of osteopathic medicine.
This ground-breaking research accomplishment will open new doors for research on neurodegenerative diseases like AMD.
The awards offered cover a wide variety of topics in vision science, including glaucoma, age-related macular degeneration, ocular cancer, amblyopia, low vision, and many more.
RPB grantees provide expert insight on geographic atrophy and dry AMD as part of the "Lunch & Learn" series.
The AUPO created a video tribute to RPB's Chairman Emeritus.
Join RPB and Apellis Pharmaceuticals for a virtual event on Feb. 25 to learn about cutting-edge research into geographic atrophy and dry AMD.
RPB grantees provide expert advice on dry AMD as part of the "Lunch & Learn" series.
The RPB Chairman Emeritus made an incredible impact on the vision research field, from his efforts to initiate support for the creation of the National Eye Institute to his decades-long leadership of RPB.
Award recipients to use IRIS Registry database to improve diagnosis and treatment of eye disease
Donald Zack, MD, PhD, is recognized for ground-breaking contributions to the field of vision research.
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
General Info | Grants | News & Resources |